MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PMGC Holdings Inc. - Common Stock (NQ:ELAB)

4.650 +0.030 (+0.65%)
Streaming Delayed Price Updated: 2:24 PM EDT, Sep 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PMGC Holdings Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
ELAB Stock Earnings: Elevai Labs Reported Results for Q1 2024 ↗
Elevai Labs just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
ELAB Stock Earnings: Elevai Labs Reported Results for Q4 2023 ↗
Elevai Labs just reported results for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries
Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries 
Via News Direct
News headline image
Elevai Labs Inc. Reports First Quarter 2024 Financial Results
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
12 Consumer Staples Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
ELEVAI Physician-Dispensed Skincare Now Available Direct to Consumers 
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are a hot topic on Thursday and we're starting the day with a breakdown of all the latest news this morning! 
Via InvestorPlace
News headline image
Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗
Shares of Palantir Technologies Inc. (NYSE: PLTR) rose sharply during today’s pre-market trading after the company reported better-than-expected fourth-quarter sales results and issued guidance. 
Via Benzinga
News headline image
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. 
Via Benzinga
News headline image
Why Is Revelation Biosciences (REVB) Stock Down 62% Today? ↗
Revelation Biosciences stock is falling on Thursday after the company announced the price of a public offering for REVB shares. 
Via InvestorPlace
News headline image
Why Is Kiora Pharmaceuticals (KPRX) Stock Up 39% Today? ↗
Kiora Pharmaceuticals stock is rising higher on Thursday as KPRX investors react to a new $45 million private placement. 
Via InvestorPlace
News headline image
Why Is Elevai Labs (ELAB) Stock Up 57% Today? ↗
Elevai Labs stock is on the rise Thursday alongside heavy trading of ELAB shares despite a lack of news from the skincare company. 
Via InvestorPlace
News headline image
Why Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗
Shares of Nextracker Inc. (NASDAQ: NXT) rose sharply during today’s pre-market trading after the company reported better-than-expected thi 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning! 
Via InvestorPlace
News headline image
ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
Utility Patent Covers the formulation for ELEVAI’s flagship exosome-based skin care products 
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Top 4 Defensive Stocks That Could Lead To Your Biggest Gains In January ↗
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket ↗
Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story